期刊文献+

标准三联疗法联合依卡倍特钠治疗幽门螺杆菌相关十二指肠球部溃疡疗效观察 被引量:3

Efficacy observation on standard triple therapy combined with ecabet sodium in treating Helicobacter pylori related duodenal bulb ulcer
下载PDF
导出
摘要 目的评价标准三联疗法联合依卡倍特钠治疗幽门螺杆菌(Hp)相关十二指肠球部溃疡的临床疗效,以及加入依卡倍特钠对提高疗效的作用。方法选择符合入选标准的Hp相关十二指肠球部溃疡患者124例,随机分为治疗组和对照组。治疗组给予依卡倍特钠1.5 g,每天2次,并联合应用奥美拉唑20 mg、克林霉素0.5 g、阿莫西林1 g,每天2次,连用7 d,对照组服用奥美拉唑20 mg、克林霉素0.5 g、阿莫西林1 g,每天2次,连用7 d。疗程结束后4周,采用14C尿素呼气试验(14C-UBT)检测Hp根除情况。结果在临床症状缓解方面及Hp根除治疗方面,治疗组均优于对照组,差异均有统计学意义(P<0.05)。结论标准三联疗法联合依卡倍特钠治疗能显著改善Hp相关十二指肠球部溃疡患者的临床症状,加入依卡倍特钠提高了标准三联疗法根除Hp的疗效。 Objective To evaluate the efficacy of standard triple therapy combined with ecabet sodium in the treatment of Helicobacter pylori (Hp) related duodenal bulb ulcer and the role adding ecabet sodium to increase the curative effects. Meth- otis 124 patients with Hp-related duodenal bulb ulcer were randomized into two groups. The therapy group received ecabetsodi- um 1.5 g, omerazole 20 mg, clarithromycin 0.5 g and amoxicillin 1 g, twice daily, for successive 7 d. The control group received omerazole 20 mg, clarithromycin 0.5 g and amoxicillin 1 g, twice daily, for successive 7 d. In 4 weeks after treatment, the eradica- tion of Hp was examined by '~C-UBT. Results The therapy group was better than contrast group in terms of alleviating the clini- cal symptoms and eradicating Hp with statisical difference between the two groups. Conclusion Standard triple therapy com- bined with eeabet sodium can significandy improve the clinical symptoms of Hp-related duodenal bulb ulcer and increase the eradication efficacy of Hp.
出处 《现代医药卫生》 2012年第13期1960-1961,共2页 Journal of Modern Medicine & Health
关键词 十二指肠溃疡/药物疗法 螺杆菌 幽门 螺杆菌感染/药物疗法 药物疗法 联合 依卡倍特钠 标准三联疗法 Duodenal ulcer/drug therapy Helicobacter pylori Helicobacter infections/therapy,drug Drug therapy,combination Ecabet sodium Standard triple therapy
  • 相关文献

参考文献7

  • 1Take S,Mizuno M,Ishiki K,et al. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease[J]. Am J Gastroenterol, 2005,100 (5) : 1037-1042.
  • 2Rokkas T,Simsek I ,Ladas S. Helico)3acter pylori and non-malignant dis- eases[J]. Helicobacter, 2007,12 Suppl 1:20-22.
  • 3Khan MK,Bemana M. Association of helicobacter pylori infection and gastric carcinoma[J]. Mymensingh Mcd J, 2012,21 ( 1 ) : 80-84.
  • 4Shibata K, Kasuga O,Yasoshima,et al. Bactericidal effect of ecabet sodium on clarithromyein-and metronidazole-resistant clinical isolates of Helieobacter pylori[J]. Jpn J Antibiot, 1997,50 (6) : 525 -531.
  • 5Murata H, Kawano S, Tsuji S, et al. Combination therapy of eeabet sodium and cimetidine compared with cimetidine alone for gastric ulcer:prospec- tive randomized multicenter study[J]. J Gastroenterol Hepatol,2003,18 (9) : 1029-1033.
  • 6Sacco F, Spezzaferro M,Amitrano M ,et al. Efficacy of four different mox- ifloxacin-based triple therapies for first-line H.pylori treatment[J]. Dig Liver Dis ,2010,42 (2) : 110-114.
  • 7Kusumoto K, Kawahara T, Kuwano , et al. Ecabet sodium inhibits Heli- cobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gustric Mucosal cetls[J]. Am I Physiol_ Gas- trointest Liver Physiol,2005,288(21* :G300-307.

同被引文献22

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部